A subsidiary of
Dr. Reddy's Laboratories Ltd.

Process development

Process development and scale up

OctoPlus has extensive experience with the development of robust, scalable processes for complex formulations such as:

  • Liposomes
  • Nanosuspensions
  • Microspheres

Key factors for our success are robustness, simplicity and scalability of production processes

Key factors for our success are robustness, simplicity and scalability which is often underestimated during the early phase of development. We help our partners to deliver a robust process ready to be transferred to commercial operations (plug and play approach) taking into account all GMP requirements.

 

OctoPlus late stage development team has extensive expertise in complex processes. We have state of the art equipment and we are following and applying Quality by Design principles.  Design of Experiments (DoE) and Real-time Statistical Process Control (SPC) are used to develop scalable processes in a timely and cost-effective way.


Contact us if you are interested in partnering up  with us!                               

 
 

 

 

Our professionals are following the Quality by Design methodology

QbD ensures quality by having a thorough understanding of all different components and processes involved in every stage of the drug development.

More information

Vision & Mission

Our vision is, either independently or in collaboration, joining forces with the academic world and industry, to make innovative injectables available to a global market. Good health can't wait.

 

Our mission is to accelerate access to affordable and innovative injectables

Contact us

Meet OctoPlus at

Controlled Release Society
26-Jul-15 - 29-Jul-15 

Edinburgh

BIO International Convention
15-Jun-15 - 18-Jun-15
Philadelphia, PA

AAPS Annual Meeting
25-Oct-15 - 29-Oct-15
Orlando, FL
 
BioEurope
2-Nov-15 - 4-Nov-15
Munich

More events

Download Press Release as PDF